Hypothalamic pathology in Huntington disease.

Area of Science:

• Neuroscience
• Genetics
• Endocrinology

Background:

• Huntington's disease (HD) is an autosomal dominant disorder caused by mutant huntingtin accumulation.
• While motor and cognitive symptoms are well-known, nonmotor symptoms, particularly those linked to the hypothalamus, are increasingly recognized.
• Hypothalamic pathology in HD involves altered neuropeptidergic populations and disrupted circuitry.

Purpose of the Study:

• To review current knowledge on hypothalamic alterations in Huntington's disease patients and animal models.
• To explore the potential clinical translation of these findings for patient management.
• To highlight therapeutic avenues targeting hypothalamic dysfunction in HD.

Main Methods:

• Review of existing literature on hypothalamic changes in Huntington's disease.
• Analysis of findings from both Huntington's disease patient studies and animal models.
• Comparison of alterations across different models and their relevance to human disease.

Main Results:

• Specific changes in hypothalamic neuropeptidergic systems are observed in HD.
• Circadian rhythm disorders and hormone excretion pattern desynchronization are common in HD patients.
• Mutant huntingtin expression and disrupted hypothalamic circuitry contribute to these alterations.

Conclusions:

• Hypothalamic pathology is a significant, yet often overlooked, aspect of Huntington's disease.
• Therapeutic interventions targeting circadian rhythm disturbances, such as light therapy or melatonin, show promise.
• Bridging the gap between animal models and clinical application requires addressing model heterogeneity, particularly repeat length variations.